"Exploring potential opportunities to continue the investigation of Leronlimab for solid tumors in oncology based on Data generated TODATE by the company."

"Einstein College of Medicine and Montefiore Medical Center located in New York studying (GBM) in infected humanized mice.
The study is expected to take place in calendar year 2024."

Unsecured promissory note @ a rate of 10% maturing in early June 2024.
actually... cheap money in this financial environment.